QQ客服 官方微博 反馈留言

	Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway
	Lu, Yao; Jiang, Zhou; Dai, Haijiang; Miao, Rujia; Shu, Jingxian; Gu, Haotian; Liu, Xing; Huang, Zhijun; Yang, Guoping; Chen, Alex F.
刊名	Hepatology
	2018
卷号	67期号:4页码:1303-1319
ISSN号	1527-3350
DOI	10.1002/hep.29633
URL标识	查看原文
WOS记录号	WOS:000428332600016
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3338030
专题	中南大学
作者单位	1.[Chen, Alex F. 2.Huang, Zhijun 3.Liu, Xing 4.Yuan, Hong 5.Lu, Yao 6.Dai, Haijiang 7.Yang, Guoping 8.Shu, Jingxian] Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Lu, Yao,Jiang, Zhou,Dai, Haijiang,et al. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway[J]. Hepatology,2018,67(4):1303-1319.
APA	Lu, Yao.,Jiang, Zhou.,Dai, Haijiang.,Miao, Rujia.,Shu, Jingxian.,...&Cai, Jingjing*.(2018).Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.Hepatology,67(4),1303-1319.
MLA	Lu, Yao,et al."Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway".Hepatology 67.4(2018):1303-1319.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。